Robot-Assisted breast surgery: a new hope for High-Risk women?
NCT ID NCT03892980
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether the da Vinci surgical robot can safely and effectively perform nipple-sparing mastectomy in 145 women at high risk for breast cancer. The goal is to see if the robot can avoid the need to switch to open surgery and to track any side effects. If it works, it could offer a less invasive option for preventive breast removal.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
da Vinci Surgical System (robot-assisted surgery device)
What this could lead to
If successful, this could show that robot-assisted nipple-sparing mastectomy is a safe and effective option for women at high risk of breast cancer, potentially reducing complications and improving cosmetic outcomes.
What could go wrong
This is an early-stage study with only 145 participants, so results may not apply to all women. There is a risk of surgical complications or the need to convert to open surgery during the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NIPPLE SPARING MASTECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
NorthShore University Health System
Evanston, Illinois, 60201, United States
-
Northwell Health
New Hyde Park, New York, 11040, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19107, United States